№7 / 2021

REVIEWS
G.R. Bikbavova, M.A. Livzan, M.M. Fedorin
Prevention of colorectal cancer in patients with inflammatory bowel disease 		8-14
K.S. Grechukhina (1, 2), K.A. Vorontsova (1), T.M. Kuko (1), A.A. Prosvirnov (1), I.P. Ganshina (3), E.V. Lubennikova (3), I.V. Kolyadina (4, 5), L.G. Zhukova (1)
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer 		15-27
O.O. Gordeeva (1), I.P. Ganshina (1), V.I. Garifullina (2)
Dermatological toxity of alpelisib: clinical experience and review of current guidelines 		28-32
V.F. Semiglazov (1, 2), R.S. Pesotsky (1), A.I. Tseluiko (1), M.A. Dzhelyalova (1), V.S. Apollonova (1), V.V. Semiglazov (1, 3)
Search for new prognostic and predictive markers of sensitivity to endocrine therapy, chemotherapy and immunotherapy of breast cancer 		33-41
A.K. Kovyazin (1), L.V. Filatova (1, 2), I.S. Zyuzgin (1), M.S. Motalkina (1), Yu.A. Chudinovskikh (1), E.V. Cherkasova (1), S.A. Volchenkov (1), S.A. Shalaev (1), I.V. Ishmatova (1), A.A. Zverkova (1), T.Yu. Semiglazova (1, 2)
Consolidation of high-dose chemotherapy with transplantation of autologous hematopoietic stem cells of the first remission of diffuse large B-cell lymphoma 		42-50
S.A. Protsenko (1), E.N. Imyanitov (1, 2), A.Yu. Malygin (1), D.O. Yurlov (1), A.I. Semenova (1), D.Kh. Latipova (1), A.V. Novik (1, 2), G.M. Teletaeva (1), G.V. Zinoviev (1), M.A. Ebert (1, 2), A.S. Artemieva (1), I.A. Baldueva (1)
Experience of using prolgolimab in real clinical practice 		51-55
R.V. Orlova (1, 2), A.A. Vakhitova (1, 2), M.I. Gluzman (1, 2)
New possibilities of neoadjuvant treatment of ER+ HER2- breast cancer in premenopausal patients 		56-60
T.L. Pilat (1), R.A. Khanferyan (2)
The effectiveness of detoxification specialized nutrition for oncological diseases 		61-66
ORIGINAL ARTICLES
A.A. Lyanova, L.Yu. Vladimirova, D.S. Kutilin, N.A. Abramova, I.L. Popova, N.M. Tikhanovskaya, M.A. Teplyakova, K.A. Novoselova, V.S. Myagkova, F.V. Alieva, L.A. Ryadinskaya
The effect of drug therapy and cetuximab on the mutational status of the KRAS gene in patients with squamous cell carcinoma of the tongue and oral floor mucosa 		68-76
N.G. Afanasyeva (1, 2), A.V. Vazhenin (1, 2), L.Yu. Trofimchuk (1), K.V. Chvanova (1)
Sentinel lymph node scintigraphy in breast cancer. Own experience 		78-80
N.A. Efremova (1), A.V. Novik (1, 2), A. Yu. Zozulya (1), T.L. Nekhaeva (1), A.B. Danilova (1), N.V. Emelyanova (1), D.V. Girdyuk (1), G.I. Gafton (1), I.A. Baldueva (1)
Immunological aspects of metronomic chemotherapy regimens 		81-86
A.K. Ivanova (1), R.V. Orlova (1, 2, 5), G.A. Raskin (3), S.I. Kutukova (1, 4)
Optimization of the tactics of adjuvant chemotherapy in patients with colon cancer taking into account clinical and morphological characteristics 		87-94
N.A. Brish (1), T.Yu. Semiglazova (1, 2), A.M. Karachun (1, 2), E.V. Tkachenko (1), A.S. Artemieva (1), L.N. Shevkunov (1), Ya.A. Ulyanchenko (1), T.S. Golovanova (1), Yu.V. Alekseeva (1), S.M. Sharashenidze (1), L.V. Strakh (3), L.V. Filatova (1, 2), V.V. Semiglazov (1, 3), B.S. Kasparov (1), S.A. Protsenko (1), A.M. Belyaev (1, 2)
Impact of nutritional deficiency and sarcopenia on the efficacy of neoadjuvant chemotherapy in patients with locally advanced gastric cancer: a retrospective study 		95-100
N.P. Belyak (1, 2), R.V. Orlova (1, 2), S.I. Kutukova (1, 3), N.V. Zhukova (1, 2), A.A. Sarmatov (2), T.S. Kesaev (1)
Assessment of the prognostic significance of clinical and morphological factors for the survival of patients with locally advanced gastric cancer after radical surgical treatment: the experience of the Russian Center 		102-109
G.G. Khakimova (1, 2), A.A. Tryakin (3), T.N. Zabotina (3)
Dynamics of indicators of systemic and local immunity during treatment in patients with gastric cancer 		110-116
A.V. Novik (1, 2), A.B. Danilova (1), T.L. Nekhaeva (1), N.V. Emelyanova (1), A.I. Semenova (1), D.Kh. Latipova (1), G.M. Teletaeva (1), S.A. Protsenko (1), I.A. Baldueva (1)
Assessment of the dynamics of immunological parameters at the beginning of therapy as prognostic and predictive factors in patients with melanoma 		118-126
E.V. Artemieva (1), F.V. Moiseenko (1, 2, 3), N.M. Volkov (1), V.V. Egorenkov (1), N.Kh. Abduloeva (1), A.A. Bogdanov (1), A.S. Zhabina (1, 2), N.V. Levchenko (1), V.M. Moiseenko (1)
Effectiveness of a shortened cycle of monoimmunotherapy in non-small cell lung cancer 		127-132
A.U. Gekhaev (1, 2), F.S. Isakova (3), E.T. Gappoeva (1)
Morphometric aspects of precancerous laryngeal hyperplastic lesions 		133-137
T.Yu. Semiglazova (1, 2), Yu.V. Alekseeva (1), E.V. Tkachenko (1), S.M. Sharashenidze (1), I.A. Baldueva (1), S.A. Volchenkov (1), A.K. Kovyazin (1), L.V. Filatova (1, 2), B.S. Kasparov (1), V.V. Semiglazov (1, 3), S.A. Protsenko (1), V.N. Anisimov (1), A.M. Belyaev (1, 3)
Features of examination and systemic treatment of malignant neoplasms in gerontological patients 		138-145
E.V. Lubennikova (1), L.G. Zhukova (2), O.O. Gordeeva (1), N.Ts. Drobot (1), A.V. Kuznetsov (3), I.P. Ganshina (1)
Olaparib – modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience 		146-150

Бионика Медиа